Recombinant Human CXXC-type zinc finger protein 11 (CXXC11)

Shipped with Ice Packs
In Stock

Description

Research Applications

This recombinant protein facilitates multiple experimental approaches:

ApplicationExperimental Use Case
DNA-Protein InteractionEMSA assays for CpG-binding specificity
Structural BiologyCrystallization trials for 3D structure determination
Drug DiscoveryHigh-throughput screening for CXXC domain inhibitors
Diagnostic DevelopmentAntibody production against native epitopes

Clinical Relevance

Emerging evidence from paralogous proteins suggests potential disease associations:

  • Cancer Biology: CXXC5 promotes breast carcinogenesis via CRL4B-NuRD complex formation

  • Immune Regulation: CXXC family members influence PD-L1 expression in tumor microenvironments

  • Metabolic Disorders: Related proteins modulate mTOR signaling pathways

These findings position CXXC11 as a candidate for investigating similar mechanisms, though direct evidence remains lacking.

Technical Considerations

Critical factors for experimental success:

  • Reducing Conditions: Required to maintain zinc finger structural integrity

  • Protease Inhibition: Essential during purification due to predicted protease cleavage sites

  • Binding Buffer Optimization: Recommended NaCl concentration <150mM for DNA interactions

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is requested. Advance notification is required for dry ice shipping, and additional charges will apply.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Before opening, briefly centrifuge the vial to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and may serve as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and the protein's inherent stability.
Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
Tag type is determined during production. Please specify your desired tag type for prioritized development.
Synonyms
RTP5; C2orf85; CXXC11; Z3CXXC5; Receptor-transporting protein 5; 3CxxC-type zinc finger protein 5; CXXC-type zinc finger protein 11
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-572
Protein Length
full length protein
Species
Homo sapiens (Human)
Target Names
RTP5
Target Protein Sequence
MDRAGADMWASTFTLAMAERKPQDVWVLLPEHSLVPGCLDGGGVQYLLVGLSRLQCGHCP GTWDSAHVHVLFHLWWDRASHRGLVKMRIWGQRCRLCPAPGDCQVRPPGEQPFLSRLVLH ILQDCYGDGPGPARHPREAYEGCCEACELGVCFLQKAPDPAWSANATKGNFPATAWGGTG TVSRGKPLSTPGDDLGKGGVVIAIPFSLVGTSNDQVPIAEGPAPPAGASLPVTGSCEALV IGQGSIFLSGDSVAMPGGKGFPVAIGDPLFHGPGLLGSSIQTFELKGFLFKGRGSLCSPV GVAQGWGPISLNNGLVPVGKHTPTVFYCVGLSASGEGSLTFPSSLTSIFTNTLSEPTDGP VATKEASITFPFIFTDVKDAVAEVAEGNGKEGGGQGLVPVGHDALPETNAGGLPSQVKGS LALPFPADVQGKDAFTDITEGKEKEGGLVTAGHDAPLEANAEGPITVSEGCITIPFAVFD VIKRKGGGHVAYGPQGNGCFSQGYYQKRQLRSRFHKARCGCRREEDERPGRACRRPHAEP YEDFWIWVSMTVCVFWLMCMCRLNPGIYPQQV
Uniprot No.

Target Background

Database Links

HGNC: 26585

KEGG: hsa:285093

UniGene: Hs.376307

Subcellular Location
Membrane; Single-pass membrane protein.

Q&A

What is CXXC11 and what is its relationship to FBXL19?

CXXC11 is a reported synonym of the FBXL19 gene, which encodes the F-box and leucine rich repeat protein 19. This protein functions in transcriptional regulation and other biological processes. The human form of CXXC11 has a canonical length of 694 amino acid residues and a molecular weight of 75.7 kilodaltons, with three known isoforms identified to date .

Methodological approaches to establish the CXXC11-FBXL19 relationship include:

  • Sequence homology analysis between CXXC11 and FBXL19 using bioinformatic tools

  • Co-expression studies to confirm coordinated regulation

  • Protein detection using antibodies against both targets

  • Functional assays demonstrating similar biological activities

What detection methods are most effective for CXXC11 in experimental settings?

Several techniques can be employed for detecting CXXC11 in research samples:

  • Antibody-based detection:

    • Western blot using commercial antibodies (e.g., CXXC11 (RTP5) Rabbit Polyclonal Antibody)

    • Immunoprecipitation for protein complex analysis

    • Immunohistochemistry/immunofluorescence for cellular localization

  • Nucleic acid-based detection:

    • RT-PCR or qPCR targeting CXXC11/FBXL19 mRNA

    • RNA-seq for transcriptome-wide expression analysis

    • In situ hybridization for tissue localization

When selecting a detection method, consider:

  • Sensitivity requirements based on expected expression levels

  • Specificity validation using appropriate controls (knockdown/knockout samples)

  • Sample type compatibility (fresh tissue, fixed cells, protein lysates)

  • Availability of validated reagents (especially antibodies)

What are the structural characteristics and domains of CXXC11?

Based on available information, human CXXC11 protein features:

  • 694 amino acid residues in its canonical form

  • 75.7 kDa molecular weight

  • Three known protein isoforms with potential functional differences

The CXXC domain typically contains two cysteine-rich clusters that coordinate zinc ions and enable DNA binding. This domain is often found in proteins involved in epigenetic regulation and transcriptional control.

For structural characterization in research settings:

  • Use bioinformatic tools to predict functional domains

  • Apply limited proteolysis to identify domain boundaries

  • Consider X-ray crystallography or NMR for detailed structural analysis

  • Perform mutagenesis studies of conserved residues to establish structure-function relationships

How should researchers design and validate CRISPR/Cas9 knockout models for CXXC11 studies?

When creating CXXC11 knockout models using CRISPR/Cas9:

  • Design considerations:

    • Target early exons to maximize disruption probability

    • Use multiple guide RNAs to improve editing efficiency

    • Consider conditional knockout strategies if complete knockout is detrimental

    • Design screening primers spanning the target region

  • Validation requirements:

    • Genomic verification through sequencing of the target locus

    • Confirmation of protein loss via Western blot

    • mRNA level assessment using qRT-PCR

    • Off-target analysis to ensure specificity

  • Control strategies:

    • Generate multiple independent knockout clones

    • Include wild-type controls from the same background

    • Consider rescue experiments with CXXC11 re-expression

Similar approaches have been successfully used for related proteins like CXXC1, where conditional knockout models were generated by inserting loxP sites flanking critical exons .

What experimental approaches can elucidate CXXC11's role in transcriptional regulation?

To investigate CXXC11's function in transcriptional regulation:

  • Chromatin association studies:

    • ChIP-seq to identify genomic binding sites

    • CUT&RUN or CUT&Tag for higher resolution binding profiles

    • DNA pull-down assays to confirm direct binding to specific sequences

  • Transcriptome analysis:

    • RNA-seq after CXXC11 knockdown/knockout to identify regulated genes

    • Time-course experiments to distinguish primary from secondary effects

    • Single-cell RNA-seq to capture cell-type specific responses

  • Protein interaction studies:

    • Immunoprecipitation followed by mass spectrometry to identify binding partners

    • Proximity labeling (BioID/TurboID) to capture transient interactions

    • Co-immunoprecipitation to validate specific interactions

  • Functional assays:

    • Luciferase reporter assays to measure effects on target promoters

    • In vitro transcription assays with purified components

    • Enhancer activity assays to test effects on distal regulatory elements

How can researchers effectively study the different isoforms of CXXC11?

With three known isoforms of CXXC11 , researchers should consider:

  • Isoform-specific detection strategies:

    • Design primers spanning unique exon junctions for RT-PCR

    • Generate isoform-specific antibodies if possible

    • Use long-read sequencing to capture full-length transcripts

  • Expression profiling:

    • Quantify relative abundance across tissues and developmental stages

    • Determine whether isoform ratios change under different conditions

    • Identify cell types with predominant expression of specific isoforms

  • Functional characterization:

    • Express individual isoforms in knockout backgrounds

    • Compare subcellular localization patterns

    • Assess differential protein interactions or DNA binding preferences

    • Evaluate isoform-specific effects on target gene expression

  • Isoform-specific manipulation:

    • Design siRNAs targeting unique regions

    • Create isoform-specific CRISPR knockouts

    • Use minigene approaches to modulate alternative splicing

Analytical ApproachApplication for Isoform StudiesTechnical Considerations
RT-PCRDetecting presence of specific isoformsRequires unique primer binding sites
qRT-PCRQuantifying relative isoform abundanceStandard curves needed for absolute quantification
Western blotConfirming protein expressionMay require high-resolution gels to separate similar-sized isoforms
Mass spectrometryIdentifying isoform-specific peptidesRequires sufficient coverage of unique regions
RNA-seqGenome-wide isoform quantificationShort reads may limit isoform discrimination

What are best practices for expression and purification of recombinant CXXC11?

For successful recombinant CXXC11 production:

  • Expression system selection:

    • Bacterial systems: Higher yield but may lack proper folding for zinc finger domains

    • Mammalian systems: Better for post-translational modifications but lower yield

    • Insect cell systems: Good compromise between yield and proper folding

  • Construct design considerations:

    • Codon optimization for the chosen expression system

    • Fusion tags selection (His, GST, MBP) based on downstream applications

    • Inclusion of protease cleavage sites for tag removal

    • Consideration of full-length vs. domain constructs

  • Purification strategy:

    • Affinity chromatography based on fusion tag

    • Ion exchange chromatography for charge-based separation

    • Size exclusion chromatography for final polishing

    • Buffer optimization to maintain zinc coordination and protein stability

  • Quality control requirements:

    • SDS-PAGE and Western blot to confirm identity and purity

    • Mass spectrometry for accurate mass determination

    • Circular dichroism to assess secondary structure

    • Thermal shift assays to evaluate stability

    • Functional assays to confirm activity (e.g., DNA binding)

How can researchers optimize antibody-based detection of CXXC11?

When working with CXXC11 antibodies (such as the CXXC11 (RTP5) Rabbit Polyclonal Antibody) :

  • Antibody validation essentials:

    • Verify specificity using knockout/knockdown controls

    • Test multiple antibodies targeting different epitopes

    • Perform peptide competition assays

    • Compare results across multiple cell types with varying expression levels

  • Western blot optimization:

    • Adjust protein loading (typically 20-50 µg total protein)

    • Optimize transfer conditions for the 75.7 kDa protein

    • Test different blocking reagents to reduce background

    • Titrate primary antibody concentration (typically 1:500 to 1:2000)

    • Extend incubation times at 4°C if signal is weak

  • Immunoprecipitation considerations:

    • Pre-clear lysates to reduce non-specific binding

    • Optimize antibody-to-bead ratios

    • Consider crosslinking approaches for transient interactions

    • Include appropriate negative controls (isotype IgG, knockout samples)

  • Immunofluorescence refinements:

    • Test different fixation methods (paraformaldehyde, methanol)

    • Optimize permeabilization conditions

    • Include antigen retrieval steps if necessary

    • Use signal amplification systems for low-abundance targets

What strategies can address inconsistent results in CXXC11 functional assays?

When troubleshooting variability in CXXC11 experimental outcomes:

Common ProblemTroubleshooting ApproachPrevention Strategy
Low signal in Western blotIncrease protein loading, extend exposure, enhance chemiluminescenceOptimize lysis buffers, use fresh samples
High background in immunostainingIncrease blocking time, dilute antibody, add additional washesUse filtered solutions, freshly prepared reagents
Inconsistent knockdown efficiencyScreen multiple siRNAs/shRNAs, optimize transfectionValidate knockdown by both protein and mRNA analysis
Variable functional readoutsIncrease replicates, use internal controlsStandardize cell density and assay conditions

How should researchers validate the specificity of CXXC11-DNA interactions?

To ensure rigorous characterization of CXXC11-DNA binding:

  • In vitro binding validation:

    • Electrophoretic mobility shift assays (EMSA) with purified protein

    • Fluorescence polarization assays to measure binding affinity

    • Surface plasmon resonance for kinetic measurements

    • DNA pull-down assays with nuclear extracts

  • Competition approaches:

    • Use unlabeled competitor DNA to demonstrate specificity

    • Test mutated binding sites to identify critical nucleotides

    • Include non-specific DNA controls

    • Perform supershift assays with CXXC11 antibodies

  • Cellular validation techniques:

    • ChIP-qPCR targeting predicted binding sites

    • Reporter assays with wild-type and mutated binding sites

    • Genome editing of putative binding sites

    • DNA fluorescence in situ hybridization (FISH) combined with protein immunofluorescence

  • Controls and standards:

    • Include known DNA-binding proteins as positive controls

    • Use mutant versions of CXXC11 lacking DNA-binding domains

    • Test binding across a range of protein concentrations

    • Validate key findings with multiple methodologies

What are the key unresolved questions about CXXC11 function in cellular processes?

Several important aspects of CXXC11 biology remain to be fully elucidated:

  • Molecular function:

    • Precise DNA binding motif preferences

    • Role in epigenetic regulation (if any)

    • Identification of direct transcriptional targets

    • Contribution to protein complexes and interaction networks

  • Cellular regulation:

    • Expression patterns across tissues and developmental stages

    • Post-translational modifications affecting activity

    • Subcellular localization and potential shuttling mechanisms

    • Turnover and degradation pathways

  • Physiological roles:

    • Function in specific developmental processes

    • Involvement in stress responses or cellular adaptation

    • Tissue-specific requirements

    • Redundancy with other CXXC-domain proteins

  • Disease relevance:

    • Potential roles in cancer or developmental disorders

    • Association with specific pathological processes

    • Utility as biomarker or therapeutic target

Future research should prioritize comprehensive characterization using integrated multi-omics approaches and functional studies in relevant physiological contexts.

How can emerging technologies advance CXXC11 research?

Novel methodologies that could significantly enhance CXXC11 investigation include:

  • Advanced genomic technologies:

    • CUT&Tag for high-resolution chromatin binding profiles

    • HiChIP for integrating chromatin conformation with protein binding

    • CRISPR screens to identify functional relationships

    • Base editing for precise modification of specific residues

  • Proteomic innovations:

    • Proximity labeling methods (TurboID, APEX) for in vivo interactome mapping

    • Cross-linking mass spectrometry for structural interaction details

    • Targeted proteomics for quantifying low-abundance isoforms

    • Protein correlation profiling for complex assembly analysis

  • Imaging advances:

    • Super-resolution microscopy for detailed localization studies

    • Live-cell imaging with tagged CXXC11 to track dynamics

    • FRET sensors to detect conformational changes or interactions

    • Lattice light-sheet microscopy for 3D visualization with minimal phototoxicity

  • Computational approaches:

    • Machine learning for predicting functional impacts of variants

    • Molecular dynamics simulations of domain interactions

    • Network analysis to position CXXC11 in cellular pathways

    • Integrative multi-omics data analysis

What considerations are important when comparing CXXC11 to other CXXC-domain proteins?

When conducting comparative studies between CXXC11 and related proteins:

  • Evolutionary relationships:

    • Perform phylogenetic analysis across species

    • Compare domain architecture and conservation

    • Analyze selective pressure on different protein regions

    • Assess evolutionary trajectories of paralogs

  • Functional comparisons:

    • Evaluate similarities and differences in DNA binding preferences

    • Compare protein interaction networks

    • Assess functional redundancy through rescue experiments

    • Determine tissue-specific expression patterns

  • Structural considerations:

    • Compare critical residues in CXXC domains

    • Analyze differences in zinc coordination

    • Evaluate domain organization and interdomain interactions

    • Assess conformational dynamics

  • Experimental approaches:

    • Use consistent methodologies for direct comparisons

    • Perform side-by-side assays under identical conditions

    • Consider chimeric proteins to isolate domain functions

    • Implement simultaneous knockdown/knockout studies to reveal redundancy

The available research on CXXC1 indicates its interaction with PRDM9 in spermatocytes and involvement in meiotic recombination, which could provide insights for investigating potential related functions of CXXC11 .

How does CXXC11 research contribute to understanding zinc finger protein biology?

CXXC11 studies can advance our knowledge of zinc finger proteins through:

  • Structural insights:

    • Contribution to understanding CXXC domain architecture

    • Elucidation of zinc coordination mechanisms

    • Clarification of DNA recognition principles

    • Identification of critical residues for function

  • Functional paradigms:

    • Models for sequence-specific DNA binding

    • Mechanisms of transcriptional regulation

    • Roles in chromatin modification and organization

    • Interplay between different zinc finger domains

  • Evolutionary perspectives:

    • Diversification of zinc finger domains

    • Functional adaptation across species

    • Selection pressures on DNA-binding domains

    • Evolution of regulatory networks

  • Methodological contributions:

    • Optimized protocols for studying zinc finger proteins

    • Improved structural analysis approaches

    • Enhanced DNA-protein interaction assessment

    • Refined computational prediction models

What interdisciplinary approaches can enhance CXXC11 functional characterization?

Integrating multiple disciplines can provide comprehensive insights into CXXC11 function:

  • Biochemistry and structural biology:

    • Determine high-resolution structures

    • Characterize enzymatic activities if present

    • Map domain interactions

    • Measure binding affinities and kinetics

  • Cell biology and genetics:

    • Assess subcellular dynamics

    • Determine phenotypic consequences of manipulation

    • Map genetic interactions

    • Evaluate contributions to cellular processes

  • Systems biology and computational approaches:

    • Model regulatory networks involving CXXC11

    • Predict functional impacts of variants

    • Integrate multi-omics datasets

    • Simulate molecular dynamics of interactions

  • Translational research connections:

    • Identify disease-relevant functions

    • Develop potential diagnostic markers

    • Explore therapeutic targeting possibilities

    • Establish relevance to human health

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.